Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
FDA approves RebiQuent treatment
Health

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
FDA approves RebiQuent treatment
Health

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
FDA approves RebiQuent treatment
Health

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

June 2, 2026 Evan Vega
PC0823Harris_Graphic_01_WEB
Infectious Disease
August 13, 2023 Evan Vega

Study shows slight differences in adverse events from COVID-19 vaccines

August 10, 2023 2 min read Source/Disclosures Disclosures: Harris reports no relevant financial disclosures. Please see the study for all

Read More
PC0823Levy_Graphic_01_WEB
Infectious Disease
August 13, 2023 Evan Vega

The struggles physicians face when starting a family

August 10, 2023 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on

Read More
Novo Nordisk to acquire Inversago Pharma, Canadian obesity drug maker
Public Health
August 13, 2023 Evan Vega

Novo Nordisk to acquire Inversago Pharma, Canadian obesity drug maker

Liselotte Sabroe | Afp | Getty Images Novo Nordisk on Thursday said it will acquire Inversago Pharma, a privately held

Read More
Clostridium_Difficile_infection 1
Infectious Disease
August 13, 2023 Evan Vega

FDA-approved microbiome therapy reduces recurrent CDI, regardless of risk factors

August 11, 2023 2 min read Source/Disclosures Published by: Disclosures: Von Moltke is employed by Seres Therapeutics. Please see the

Read More
Surgical_Masks 1
Infectious Disease
August 12, 2023 Evan Vega

Clinicians should consider masking during elevated respiratory viral activity, experts say

August 12, 2023 2 min read Source/Disclosures Published by: Disclosures: Klompas reports receiving institutional grant funding from AHRQ, CDC, and

Read More
10 drugs that are likely targets for fall Medicare price negotiations
Public Health
August 12, 2023 Evan Vega

10 drugs that are likely targets for fall Medicare price negotiations

Merck & Co. Inc.’s Januvia brand medication, used to treat Type 2 diabetes. Daniel Acker | Bloomberg | Getty Images

Read More
Generic Breaking News infographic
Infectious Disease
August 12, 2023 Evan Vega

Suicide deaths in US reached new height in 2022

August 11, 2023 2 min read Source/Disclosures Disclosures: Becerra, Houry and Murthy report no relevant financial disclosures. ADD TOPIC TO

Read More
Source: Adobe Stock
Infectious Disease
August 12, 2023 Evan Vega

Women with HIV face greater age-related comorbidity burden

August 11, 2023 2 min read Source/Disclosures Disclosures: Collins reports receiving honoraria from Curio Sciences during the conduct of the

Read More
SEC investigating Illumina over Grail acquisition
Public Health
August 11, 2023 Evan Vega

SEC investigating Illumina over Grail acquisition

A building on the campus at the world headquarters of Illumina is shown in San Diego, California, Sept. 1, 2021.

Read More
IDN0823CovidEG5_Graphic_01_WEB
Infectious Disease
August 11, 2023 Evan Vega

EG.5 emerges as dominant variant amid summer wave of COVID-19

August 11, 2023 3 min read Source/Disclosures Published by: Source: Healio Interviews Disclosures: Li reports consulting for AbbVie and receiving

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.